These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 39421021)
1. CAR-macrophage: Breaking new ground in cellular immunotherapy. Huang T; Bei C; Hu Z; Li Y Front Cell Dev Biol; 2024; 12():1464218. PubMed ID: 39421021 [TBL] [Abstract][Full Text] [Related]
2. CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond. Lu J; Ma Y; Li Q; Xu Y; Xue Y; Xu S Biomark Res; 2024 Aug; 12(1):86. PubMed ID: 39175095 [TBL] [Abstract][Full Text] [Related]
3. Revolutionizing Cancer Treatments through Stem Cell-Derived CAR T Cells for Immunotherapy: Opening New Horizons for the Future of Oncology. Mishra HK; Kalyuzhny A Cells; 2024 Sep; 13(18):. PubMed ID: 39329700 [TBL] [Abstract][Full Text] [Related]
4. CAR designs for solid tumors: overcoming hurdles and paving the way for effective immunotherapy. Cui Y; Luo M; Gu C; He Y; Yao Y; Li P Biophys Rep; 2023 Oct; 9(5):279-297. PubMed ID: 38516299 [TBL] [Abstract][Full Text] [Related]
5. Advancing cellular immunotherapy with macrophages. Mishra AK; Malonia SK Life Sci; 2023 Sep; 328():121857. PubMed ID: 37307965 [TBL] [Abstract][Full Text] [Related]
6. Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors. Sloas C; Gill S; Klichinsky M Front Immunol; 2021; 12():783305. PubMed ID: 34899748 [TBL] [Abstract][Full Text] [Related]
7. Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review). Poojary R; Song AF; Song BS; Song CS; Wang L; Song J Mol Clin Oncol; 2023 Dec; 19(6):95. PubMed ID: 37920415 [TBL] [Abstract][Full Text] [Related]
8. Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer. Gorchakov AA; Kulemzin SV; Kochneva GV; Taranin AV Eur Urol; 2020 Mar; 77(3):299-308. PubMed ID: 31471138 [TBL] [Abstract][Full Text] [Related]
9. Emerging advances in nanobiomaterials-assisted chimeric antigen receptor (CAR)-macrophages for tumor immunotherapy. Zhang Y; Yang J; Zhang T; Gu H Front Bioeng Biotechnol; 2023; 11():1211687. PubMed ID: 37388769 [TBL] [Abstract][Full Text] [Related]
10. CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar. Chen K; Liu ML; Wang JC; Fang S Biomol Biomed; 2024 May; 24(3):465-476. PubMed ID: 37877819 [TBL] [Abstract][Full Text] [Related]
11. Recent advances and progress in immunotherapy of solid cancers. Kumar A; Emdad L; Das SK; Fisher PB Adv Cancer Res; 2024; 164():111-190. PubMed ID: 39306365 [TBL] [Abstract][Full Text] [Related]
12. Recent Advances in CAR-Based Solid Tumor Immunotherapy. Shin MH; Oh E; Kim Y; Nam DH; Jeon SY; Yu JH; Minn D Cells; 2023 Jun; 12(12):. PubMed ID: 37371075 [TBL] [Abstract][Full Text] [Related]
13. Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game. Ku KS; Tang J; Chen Y; Shi Y Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791398 [TBL] [Abstract][Full Text] [Related]
14. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients. Marofi F; Rahman HS; Al-Obaidi ZMJ; Jalil AT; Abdelbasset WK; Suksatan W; Dorofeev AE; Shomali N; Chartrand MS; Pathak Y; Hassanzadeh A; Baradaran B; Ahmadi M; Saeedi H; Tahmasebi S; Jarahian M Stem Cell Res Ther; 2021 Aug; 12(1):465. PubMed ID: 34412685 [TBL] [Abstract][Full Text] [Related]
15. Advances in CAR-NK cell therapy for hematological malignancies. Yang R; Yang Y; Liu R; Wang Y; Yang R; He A Front Immunol; 2024; 15():1414264. PubMed ID: 39007146 [TBL] [Abstract][Full Text] [Related]
16. Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils. Liang Y; Xu Q; Gao Q Front Immunol; 2023; 14():1291619. PubMed ID: 38090576 [TBL] [Abstract][Full Text] [Related]
17. Challenges and new technologies in adoptive cell therapy. Zhang P; Zhang G; Wan X J Hematol Oncol; 2023 Aug; 16(1):97. PubMed ID: 37596653 [TBL] [Abstract][Full Text] [Related]
18. CAR-T in cancer therapeutics and updates. Zhu S J Natl Cancer Cent; 2024 Sep; 4(3):189-194. PubMed ID: 39281717 [TBL] [Abstract][Full Text] [Related]
19. Revolutionizing cancer immunotherapy in solid tumor: CAR engineering and single-cell sequencing insights. Pu Z; Wang TB; Mou L Front Immunol; 2023; 14():1310285. PubMed ID: 38090577 [TBL] [Abstract][Full Text] [Related]
20. M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors. Huo Y; Zhang H; Sa L; Zheng W; He Y; Lyu H; Sun M; Zhang L; Shan L; Yang A; Wang T J Transl Med; 2023 Mar; 21(1):225. PubMed ID: 36978075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]